Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory

Medical Journal of Australia

Volumn 194, Issue 11, 2011, Pages 579-582

  Trauer, James M ^a   Krause, Vicki L ^a  

^a Centre for Disease Control   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HEMOGLOBIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; ISONIAZID; LIVER ENZYME; PYRIDOXINE; TUBERCULIN; VITAMIN D;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANOREXIA; ARTHRALGIA; ARTICLE; AUSTRALIA; BACTERIUM CULTURE; BIRTHPLACE; BLOOD SMEAR; CALCIUM BLOOD LEVEL; CHILD; CONTROLLED STUDY; DEPRESSION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; EOSINOPHIL COUNT; ETHNIC DIFFERENCE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION PREVENTION; LATENT TUBERCULOSIS; LETHARGY; LEUKOCYTE COUNT; LUNG GRANULOMA; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL HISTORY; NAUSEA; PARASITE IDENTIFICATION; PATIENT COMPLIANCE; PREVALENCE; REFUGEE; SCAR FORMATION; SCHISTOSOMIASIS; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT REFUSAL; TUBERCULIN TEST; VISUAL DISORDER; VITAMIN BLOOD LEVEL; VOMITING;

EID: 79958795154     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2011.tb03108.x     Document Type: Article

References (25)

1. Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-2050: cure, care, and social development. Lancet 2010; 375: 1814-1829.
2. Al-Orainey IO. Diagnosis of latent tuberculosis: can we do better? Ann Thorac Med 2009; 4: 5-9.
3. Smieja MJ, Marchett CA, Cook DJ, et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000; (2): CD001363.
4. Moulding T. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 2000; 4: 485-487.
5. Horsburgh CR. Priorities for the treatment of latent tuberculosis in the United States. N Engl J Med 2004; 350: 2060-2067.
6. Centre for Disease Control. Guidelines for the control of tuberculosis in the Northern Territory. 4th ed. Darwin: Northern Territory Government Department of Health and Community Services, 2008.
7. Arshad S, Bavan L, Gajari K, et al. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J 2010; 35: 1336-1345.
8. Vynnycky E, Borgdorff MW, Leung CC, et al. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol Infect 2008; 136: 943-952.
9. Victorian Government Department of Human Services. Management, control and prevention of tuberculosis: guidelines for health care providers 2002-2005. Melbourne: DoHS, 2002. http:// www.health.vic.gov.au/__data/assets/pdf_file/0006/ 19986/tb_mgmt_guide.pdf (accessed Oct 2009).
10. Marks GB, Bai J, Simpson SE, et al. Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med 2000; 162: 1851-1854.
11. Sterling TR, Bethel J, Goldberg S, et al. Tuberculosis Epidemiologic Studies Consortium. The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am J Respir Crit Care Med 2006; 173: 927-931.
12. Coker R, Bell A, Pitman R, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J 2006; 27: 801-807.
13. Tiong AC, Patel MS, Gardiner J, et al. Health issues in newly arrived African refugees attending general practice clinics in Melbourne. Med J Aust 2006; 185: 602-606.
14. Lucas M, Nicol P, McKinnon E, et al. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax 2010; 65: 442-448.
15. World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing. Geneva: WHO Press, 2009.
16. World Health Organization. TB profile: Somalia. https://extranet.who.int/sree/Reports?op= Replet&name=%2FWHO_HQ_Reports%2FG 2%2FPROD%2FEXT%2FTBCountryProfile&ISO2= SO&outtype=pdf (accessed May 2011).
17. World Health Organization. TB profile: Sudan. https://extranet.who.int/sree/Reports?op= Replet&name=%2FWHO_HQ_Reports%2FG2 %2FPROD%2FEXT%2FTBCountryProfile&ISO2= SD&outtype=pdf (accessed May 2011).
18. Horsburgh CR Jr, Goldberg S, Bethel J, et al. Tuberculosis Epidemiologic Studies Consortium. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 2010; 137: 401-409.
19. Parsyan AE, Saukkonen J, Barry MA, et al. Predictors of failure to complete treatment for latent tuberculosis infection. J Infect 2007; 54: 262-266.
20. LoBue PA, Moser KS. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003; 168: 443.
21. Li J, Munsiff SS, Tarantino T, et al. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis 2010; 14: e292-e297.
22. Hirsch-Moverman Y, Daftary A, Franks J, et al. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008; 12: 1235-1254.
23. Levesque JF, Dongier P, Brassard P, et al. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis 2004; 8: 711-717.
24. Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007; 4: e238.
25. Goldberg SV, Wallace J, Jackson JC, et al. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis 2004; 8: 76-82.